Holding(s) in Company

AI SummaryClose X

Lanstead Capital Investors LP has acquired a significant stake in Immupharma plc, now holding 17.99% of the company's voting rights. This acquisition represents a substantial increase from their previous holding, which was below 3%. The total number of voting rights in Immupharma plc is 623,911,379. This notification was made on April 9, 2026, following the threshold crossing on April 8, 2026.

Disclaimer*

Companies

Immupharma (IMM)
UK 100

Latest directors dealings